| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $101.5M | +21.4% |
| Cost of Revenue | $84.0M | +12.1% |
| Gross Profit | $17.5M | +100.9% |
| R&D Expense | $19K | -98.3% |
| SG&A Expense | $14.1M | +16.2% |
| Operating Income | $608K | +109.1% |
| Pre-tax Income | -$480K | +94.3% |
| Income Tax | $0 | — |
| Net Income | -$480K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.7M | +74.4% |
| Accounts Receivable | $8.3M | -23.9% |
| Inventory | $5.8M | -1.6% |
| Current Assets | $37.0M | +28.7% |
| Total Assets | $59.2M | +13.5% |
| Current Liabilities | $14.1M | -15.3% |
| Long-term Debt | $8.5M | +2.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.2M | +144.6% |
| Investing Cash Flow | -$4.9M | -59.8% |
| Financing Cash Flow | $7.3M | -35.2% |
| +94.3% |
| EPS (Basic) | -$0.03 | +91.9% |
| EPS (Diluted) | -$0.03 | +91.9% |
| Total Liabilities |
| $26.6M |
| -13.8% |
| Stockholders' Equity | $32.6M | +53.1% |